Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $932.47M.
ENTERPRISE VALUE (EV)
$932.47M
Castle Biosciences, Inc.
Market Cap
$1.04B
Enterprise Value (EV)
$932.47M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.04B | $932.47M |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | $2.86B |
| Immatics N.V. (IMTX)vs › | $1.03B | $784.49M |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | $1.31B |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | $1.01B |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | $1.92B |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | $934.46M |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $997.88M | N/A |
| IRadimed Corporation (IRMD)vs › | $1.08B | $1.02B |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | $992.57M |
Market Cap
$1.04B
Total Debt
$10.06M
Cash
$116.73M
Enterprise Value
$932.47M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
